Company

Neoclease

Biotechnology Research Boston, Massachusetts, United States 4 employees

Employees: 4
Contacts: 1
Emails: 1

www.neoclease.ai LinkedIn

Neoclease Overview

Headquarters: Boston, Massachusetts, United States
Website: www.neoclease.ai
Industry: Biotechnology Research
Employees: 4
Founded: 2022
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

gene editing synthetic biology AI/ML for drug discovery neurodegeneration protein engineering gene therapy

About Neoclease

Neoclease is a biotechnology company pioneering AI-designed gene-editing therapies optimized for individual genes. Using a proprietary platform that integrates generative protein models with synthetic biology, Neoclease builds ultra-precise, delivery-ready nucleases for diseases with high unmet need. Its lead program targets LRRK2 to halt progression of Parkinson’s disease. Neoclease’s approach enables the development of editors with enhanced specificity, efficiency, and size, unlocking new possibilities across thousands of genetic diseases.